نتایج جستجو برای: acute infantile gaucher disease

تعداد نتایج: 1877238  

2015
Tamer M. Rizk Rafiu O. Ariganjoye Gihad I. Alsaeed

ةيداع ريغ ةيريرس تاملاع نم يناعي تاونس 8 هرمع يبص انفصو نم ضرم وه "رشوج" ضرم .ةرمدم جئاتن عم رشوج ضرم نم صقن نع جتنيو ةنمزلما ةيموزوزيللا نيزختلا تابارطضا ضارمأ رهاظبم "رشوج" ضرم زيمتي "زيديسوربيريسوكولج" يمزنأ يف .يعانلما زاهلجا رثأت ىلع يوطنت ام اًبلاغ نكلو ةفلتخم ةيريرس ساسأ ىلع "رشوج" ضرلم ةزيمتم ةيعرف عاونأ 3 تفصو دقل صيخشت متيو .يبصعلا زاهلجا رثأت ضارعأ بايغ وأ دوجو روتح ةسارد ،طاشنلا صحف ...

2014
Laura van Dussen Marieke Biegstraaten Marcel GW Dijkgraaf Carla EM Hollak

Long-term complications and associated conditions of type 1 Gaucher Disease (GD) can include splenectomy, bone complications, pulmonary hypertension, Parkinson disease and malignancies. Enzyme replacement therapy (ERT) reverses cytopenia and reduces organomegaly. To study the effects of ERT on long-term complications and associated conditions, the course of Gaucher disease was modelled.

Journal: :Archives of internal medicine 1998
D Kronn V Jansen H Ostrer

BACKGROUND By late 1993, the genes for cystic fibrosis and Gaucher disease and the mutations common among Ashkenazi Jews had been identified. In response to these advances, heterozygote screening for cystic fibrosis and Gaucher disease was added to the more than 20-year-old Tay-Sachs disease screening program at New York University Medical Center, New York, NY. OBJECTIVE To review the outcome...

Journal: :Metabolism: clinical and experimental 2007
Mirjam Langeveld Saskia Scheij Peter Dubbelhuis Carla E M Hollak Hans P Sauerwein Peter Simons Johannes M F G Aerts

Gaucher disease (glucocerebrosidase deficiency) is characterized by massive accumulation of lipid-laden macrophages in various tissues. Patients with Gaucher disease show a hitherto unexplained increase in hepatic glucose output. Because adiponectin is thought to influence hepatic glucose output, we studied its serum concentration in a cohort of patients with Gaucher disease. Serum adiponectin ...

2016
Wendy Westbroek Matthew Nguyen Marina Siebert Taylor Lindstrom Robert A Burnett Elma Aflaki Olive Jung Rafael Tamargo Jorge L Rodriguez-Gil Walter Acosta An Hendrix Bahafta Behre Nahid Tayebi Hideji Fujiwara Rohini Sidhu Benoit Renvoise Edward I Ginns Amalia Dutra Evgenia Pak Carole Cramer Daniel S Ory William J Pavan Ellen Sidransky

Glucocerebrosidase is a lysosomal hydrolase involved in the breakdown of glucosylceramide. Gaucher disease, a recessive lysosomal storage disorder, is caused by mutations in the gene GBA1 Dysfunctional glucocerebrosidase leads to accumulation of glucosylceramide and glycosylsphingosine in various cell types and organs. Mutations in GBA1 are also a common genetic risk factor for Parkinson diseas...

Journal: :Human molecular genetics 1994
F Y Choy C Wei D A Applegarth S L Yong

Gaucher disease is the most prevalent inherited sphingolipidosis (1). It results from deficient glucocerebrosidase activity and is transmitted as an autosomal recessive trait (2). Three clinical forms of Gaucher disease have been described: Type 1, nonneuronopathic; type 2, acute neuronopathic; and type 3, subacute neuronopathic (1). The gene frequency of Gaucher disease in the Jewish populatio...

2017
Mario de la Mata David Cotán Manuel Oropesa-Ávila Marina Villanueva-Paz Isabel de Lavera Mónica Álvarez-Córdoba Raquel Luzón-Hidalgo Juan M. Suárez-Rivero Gustavo Tiscornia José A. Sánchez-Alcázar

BACKGROUND Gaucher disease (GD) is caused by mutations in the GBA1 gene which encodes lysosomal β-glucocerebrosidase (GCase). In GD, partial or complete loss of GCase activity causes the accumulation of the glycolipids glucosylceramide (GlcCer) and glucosylsphingosine in the lysosomes of macrophages. In this manuscript, we investigated the effects of glycolipids accumulation on lysosomal and mi...

Journal: :Journal of Clinical Movement Disorders 2017

2016
Christine Serratrice Sebastian Carballo Jacques Serratrice Jérome Stirnemann

INTRODUCTION Gaucher disease is the first lysosomal disease to benefit from enzyme replacement therapy, thus serving as model for numerous other lysosomal diseases. Alglucerase was the first glucocerebrosidase purified from placental extracts, and this was then replaced by imiglucerase - a Chinese hamster ovary cell-derived glucocerebrosidase. AIM The aim was to review the evidence underlying...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید